| Prev Close | 60.90 |
| Day Low/High | 60.44 / 61.08 |
| 52 Wk Low/High | 46.86 / 63.84 |
| Avg Volume | 2.49M |
| Exchange | NYSE |
| Shares Outstanding | 489.11M |
| Market Cap | 29.79B |
| EPS | 1.70 |
| P/E Ratio | 34.41 |
| Div & Yield | 0.42 (0.70%) |
Latest News
Zoetis Announces Second Quarter 2017 Results
Zoetis Inc. (NYSE:ZTS) today reported its financial results for the second quarter of 2017 and increased its full year guidance for revenue and net income.
Zoetis Appoints Dr. Linda Rhodes To Board Of Directors
Zoetis Inc. (NYSE: ZTS) today announced the appointment of Dr.
Zoetis Completes Acquisition Of Nexvet Biopharma
Zoetis Inc. (NYSE:ZTS) and Nexvet Biopharma plc (Nasdaq:NVET) today announced that Zoetis has completed the acquisition of Nexvet, a biologic therapeutics company developing a pipeline of monoclonal antibody (mAb)...
Zoetis To Host Webcast And Conference Call On Second Quarter 2017 Financial Results
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.
Who's Afraid of the Amazon Empire?: Cramer's 'Mad Money' Recap (Thursday 6/22/17)
Jim Cramer doesn't buy the backlash against Amazon. He says Prime is a very powerful tool and an irresistible bargain.
Citigroup, Zoetis, AbbVie, Mattel, Valeant Pharmaceuticals 'Mad Money' Lightning Round
Jim Cramer is bullish on Citigroup, Zoetis, Idexx Labs, AbbVie, Nucor, and Alexion.
Zoetis To Participate In The William Blair Growth Stock Conference
Zoetis Inc. (NYSE:ZTS) will participate in the William Blair Growth Stock Conference on Tuesday, June 13, 2017, in Chicago, Ill.
Zoetis To Participate In The Stifel 2017 Dental And Veterinary Conference
Zoetis Inc. (NYSE:ZTS) will participate in the Stifel 2017 Dental and Veterinary Conference on Wednesday, May 31, 2017, in New York, N.
Zoetis: Cramer's Top Takeaways
Juan Ramon Alaix, CEO of Zoetis, tells Jim Cramer about opportunities in the market for companion animal and livestock vaccines.
Industrials Are Stalling, Techs Are Roaring: Cramer's 'Mad Money' Recap (Monday 5/15/17)
Jim Cramer says investors are migrating toward sectors likely to have the biggest upside in the second half.
Zoetis Declares Third Quarter 2017 Dividend
The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a third quarter 2017 dividend payable to holders of the company's common stock of $0.
Zoetis Holds Annual Meeting Of Shareholders
Speaking to shareholders at the Zoetis Inc. (NYSE:ZTS) annual meeting today in Short Hills, N.
Forbes Names Zoetis One Of America's Best Employers For Second Year In A Row
Zoetis Inc. (NYSE:ZTS), the global leader in animal health, today announced that it has been named one of America's Best Midsize Employers by Forbes Magazine for the second year in a row.
Photo: Bill & Melinda Gates Foundation/Mulugeta Ayene
Zoetis Inc. (NYSE:ZTS), the largest global animal health company, announced it will receive a US$14.
Oil Slide Puts Market Into Rotation: Cramer's 'Mad Money' Recap (Thursday 5/4/17)
Gyrations hit market, as traders drop oil, buy safety.
Cramer: As Fed Moves to Tighten, Other Things Come Unraveled
The list begins with oil, but there's a ripple effect.
Market Recon: The Reflation Trade Still Lives, but Buckle Your Chinstrap
The Fed's intent is still as plain to see as it was late last year. This committee remains on mission.
Zoetis Announces First Quarter 2017 Results
Zoetis Inc. (NYSE:ZTS) today reported its financial results for the first quarter of 2017 and reaffirmed its guidance for full year 2017.
Zoetis To Participate In The Bank Of America Merrill Lynch Health Care Conference
Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Merrill Lynch Health Care Conference on Wednesday, May 17, 2017, in Las Vegas, Nev.
Zoetis Has Received European Commission Marketing Authorization For Cytopoint (lokivetmab), The First Monoclonal Antibody (mAb) Therapy Approved In The European Union For Veterinary Use. Photo: Zoetis
Zoetis Inc. (NYSE:ZTS) today announced that the European Commission has granted the company marketing authorization for Cytopoint (lokivetmab), the first monoclonal antibody (mAb) therapy approved in the European...
Zoetis To Acquire Nexvet Biopharma, An Innovator In Monoclonal Antibody Therapies For Companion Animals
Zoetis Inc. (NYSE:ZTS) and Nexvet Biopharma plc (Nasdaq:NVET) today announced an agreement in which Zoetis, through a wholly owned subsidiary ("Zoetis Bidco"), will purchase Nexvet, an innovator in monoclonal...
Nick Lachey's Dog, Wookie. Photo: Zoetis.
Zoetis Inc. (NYSE:ZTS), the leading global animal health company, today announced that music and television star Nick Lachey* is teaming up with the company to launch Your Animal Instinct , a program to help your...
Zoetis To Host Webcast And Conference Call On First Quarter 2017 Financial Results
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.
Halliburton, Schlumberger, Alcoa, Celgene:'Mad Money' Lightning Round (3/29/17)
Jim Cramer is bullish on Halliburton, Schlumberger, Cypress Semiconductor and Celgene
This Market Loves Tech: Cramer's 'Mad Money' Recap (Wednesday 3/29/17)
Tech's organic growth and visibility has been apparent all year, says Jim Cramer.
Impax Gains 38% On CEO Appointment, Talk of Sale
The company hired Paul Bisaro, former chairman at Allergan, to become CEO as Morgan Stanley helps explore alternatives, including a sale.
Zoetis Moves Up In Analyst Rankings, Passing Alphabet
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Zoetis Inc has taken over the #25 spot from Alphabet Inc , according to ETF Channel. Below is a chart of Zoetis Inc versus Alphabet Inc plotting their respective rank within the S&P 500 over time (ZTS plotted in blue; GOOGL plotted in green): In forming the rank, the analyst opinions from the major brokerage houses were tallied, and averaged; then, the underlying components were ranked according to those averages.
Zoetis To Participate In The Jefferies Animal Health Summit
Zoetis Inc. (NYSE:ZTS) will participate in the Jefferies Animal Health Summit on Thursday, March 30, 2017, in New York, N.
